Consent Forms | ioclinicalnetwork.co.uk

Home
About Us
- IOCN Policies & Governance
- Disclaimer and Conditions of Use Policy
Clinical Support
Education & Training
Policy & Governance
Research & Analysis
- Translational Research
Service Development
Join Us

enquiries@ioclinicalnetwork.co.uk

@IOClinicalNet

Home
About Us
Clinical Support
Education & Training
Policy & Governance
Research & Analysis
Service Development
Join Us

IOCN

The Immuno-Oncology Clinical Network

Consent Forms

Cancer Research UK (CRUK) Consent forms for Systemic Anti-Cancer Treatment (SACT)

Immunotherapy regimens:

Atezolizumab
Avelumab
Durvalumab
Ipilimumab
Ipilimumab and Nivolumab
Nivolumab
Pembrolizumab

Immunotherapy combination treatment:

Atezolizumab, Bevacizumab, Caroplatin and Paclitaxel
Atezolizumab, Caroplatin and Etoposide
Avelumab and Axitinib
Carboplatin, Paclitaxel and Pembrolizumab
Carboplatin, Pemetrexed and Pembrolizumab
Cisplatin, Pemetrexed and Pembrolizumab

Registered Charity In England and Wales

Charitable Number: 1205140

Join Us: Become a Member of the IOCN

IOCN Disclaimer and Conditions of User Policy